These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption. Papapoulos SE, Frölich M. J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849 [Abstract] [Full Text] [Related]
27. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate]. Miravet L, Kuntz D. Rev Rhum Mal Osteoartic; 1989 Mar 15; 56(4):287-92. PubMed ID: 2496460 [Abstract] [Full Text] [Related]
36. (Chloro-4 phenyl) thiomethylene biphosphonate in Paget's bone disease. Reginster JY, Deroisy R, Lecart MP, Franchimont P. Acta Belg Med Phys; 1989 Mar 15; 12(2):47-52. PubMed ID: 2603591 [Abstract] [Full Text] [Related]
37. A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone. Chakravarty K, Merry P, Scott DG. J Rheumatol; 1994 Nov 15; 21(11):2118-21. PubMed ID: 7869320 [Abstract] [Full Text] [Related]